GlobalData on MSN
FDA rejects Regeneron’s Eylea HD amid filling facility woes
Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in January 2026.
LONDON (Reuters) - Contract drug manufacturers seeking to tap into the booming market for weight-loss drugs are investing billions of dollars to expand or build factories that fill the injection pens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback